Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. News
  7. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
Real-time Estimate Cboe BZX  -  05/16 03:46:49 pm EDT
50.65 USD   +1.45%
11:52aGLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
10:39aWALL STREET STOCK EXCHANGE : China added to the list of investors' fears
08:08aPfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pzifer, OPKO Health Evaluating FDA's Complete Response Letter on Growth Hormone Replacement

01/21/2022 | 04:46pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
OPKO HEALTH, INC. -0.83% 2.955 Delayed Quote.-37.01%
PFIZER, INC. 1.43% 50.835 Delayed Quote.-15.46%
All news about PFIZER, INC.
11:52aGLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
10:39aWALL STREET STOCK EXCHANGE : China added to the list of investors' fears
08:08aPfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European C..
AQ
07:11aINSIDER SELL : Pfizer
MT
05/15Pfizer, BioNTech Agree To Move Delivery Schedules For COVID-19 Vaccines In EU
MT
05/13Pfizer Files Lawsuit In Australia To Halt Sales Of BRENZYS (Etanercept)
AQ
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/12PFIZER, INC. : Ex-dividend day for
FA
05/11PFIZER INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 104 B - -
Net income 2022 35 223 M - -
Net cash 2022 10 478 M - -
P/E ratio 2022 8,35x
Yield 2022 3,25%
Capitalization 280 B 280 B -
EV / Sales 2022 2,59x
EV / Sales 2023 3,40x
Nbr of Employees 79 000
Free-Float 58,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 49,92 $
Average target price 57,79 $
Spread / Average Target 15,8%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-15.46%280 096
JOHNSON & JOHNSON3.38%465 363
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421
NOVO NORDISK A/S1.92%238 221